Adenomyosis in mice.

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (11)

• Unveiling the Pathogenesis of Adenomyosis through Animal Models 2022
• In the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis 2021
• Effects of Ovarian Pathologies and Uterine Inflammations on Adenomyosis in Bitches 2018
• <i>β</i> ‐Catenin activation contributes to the pathogenesis of adenomyosis through epithelial–mesenchymal transition 2013
• Methodological Issues in Preclinical Mouse Efficacy Studies of Adenomyosis 2012
• Neonatal administration of tamoxifen causes disruption of myometrial development but not adenomyosis in the C57/BL6J mouse 2010
• Adenomyosis—A Result of Disordered Stromal Differentiation 2001
• Identification of focal adenomyosis as a uterine lesion in two dogs 2001
• Animal model of uterine adenomyosis: Is prolactin a potent inducer of adenomyosis in mice? 1991
• Multiple Endocrine Syndrome in SHN Mice: Mammary Tumors and Uterine Adenomyosis 1989
• Effects of prenatal exposure of mice to “low-dose” diethylstilbestrol and the development of adenomyosis associated with evidence of hyperprolactinemia 1982

Source provenance

europepmc

last seen: 2026-06-13T06:22:48.782012+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:10:10.897782+00:00